1. Repository of OAI
Ελληνικά   English  

Browsing by Author Briasoulis, E.

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Jump to: Α Β Γ Δ Ε Ζ Η Θ Ι Κ Λ Μ Ν Ξ Ο Π Ρ Σ Τ Υ Φ Χ Ψ Ω
or enter first few letters:  
View Option
Showing results 36 to 55 of 126 < previous   next >
TitleAuthor(s)Issue date???itemlist.???
The dawn of Clinical Oncology education in GreeceBriasoulis, E.; Kardamakis, D.24-Nov-2015-
Diagnostic and therapeutic management of cancer of an unknown primaryPavlidis, N.; Briasoulis, E.; Hainsworth, J.; Greco, F. A.24-Nov-2015-
Docetaxel and carboplatin combination chemotherapy as outpatient palliative therapy in carcinoma of unknown primary: a multicentre Hellenic Cooperative Oncology Group phase II studyPentheroudakis, G.; Briasoulis, E.; Kalofonos, H. P.; Fountzilas, G.; Economopoulos, T.; Samelis, G.; Koutras, A.; Karina, M.; Xiros, N.; Samantas, E.; Bamias, A.; Pavlidis, N.24-Nov-2015-
Docetaxel in combination with dacarbazine in patients with advanced melanomaBafaloukos, D.; Aravantinos, G.; Fountzilas, G.; Stathopoulos, G.; Gogas, H.; Samonis, G.; Briasoulis, E.; Mylonakis, N.; Skarlos, D. V.; Kosmidis, P.24-Nov-2015-
Dose-ranging study of metronomic oral vinorelbine in patients with advanced refractory cancerBriasoulis, E.; Pappas, P.; Puozzo, C.; Tolis, C.; Fountzilas, G.; Dafni, U.; Marselos, M.; Pavlidis, N.24-Nov-2015-
Epithelial ovarian cancer in Greece: a retrospective study of 1,791 patients by the Hellenic Cooperative Oncology Group (HeCOG)Pectasides, D.; Papaxoinis, G.; Fountzilas, G.; Aravantinos, G.; Bamias, A.; Pavlidis, N.; Kalofonos, H. P.; Timotheadou, E.; Samantas, E.; Briasoulis, E.; Skarlos, D. V.; Economopoulos, T.; Dimopoulos, M. A.24-Nov-2015-
Epithelial ovarian carcinoma in younger vs older women: is age an independent prognostic factor? The Hellenic Oncology Cooperative Group experiencePectasides, D.; Fountzilas, G.; Aravantinos, G.; Bamias, A.; Kalofonos, H. P.; Skarlos, D.; Briasoulis, E.; Konstantara, A.; Economopoulos, T.; Dimopoulos, M. A.24-Nov-2015-
ESMO Minimum Clinical Recommendations for diagnosis, treatment and follow-up of cancers of unknown primary site (CUP)Briasoulis, E.; Tolis, C.; Bergh, J.; Pavlidis, N.24-Nov-2015-
Estrogen receptor beta (ERbeta) expression in breast carcinomas is not correlated with estrogen receptor alpha (ERalpha) and prognosis: the Greek experienceStefanou, D.; Batistatou, A.; Briasoulis, E.; Arkoumani, E.; Agnantis, N. J.24-Nov-2015-
Evaluation of the prognostic and predictive value of HER family mRNA expression in high-risk early breast cancer: a Hellenic Cooperative Oncology Group (HeCOG) studyKoutras, A. K.; Kalogeras, K. T.; Dimopoulos, M. A.; Wirtz, R. M.; Dafni, U.; Briasoulis, E.; Pectasides, D.; Gogas, H.; Christodoulou, C.; Aravantinos, G.; Zografos, G.; Timotheadou, E.; Papakostas, P.; Linardou, H.; Razis, E.; Economopoulos, T.; Kalofonos, H. P.; Fountzilas, G.24-Nov-2015-
Evaluation of the prognostic and predictive value of HER-1/EGFR in breast cancer patients participating in a randomized study with dose-dense sequential adjuvant chemotherapyTzaida, O.; Gogas, H.; Dafni, U.; Kyroudi, A.; Papaspyrou, I.; Kyriakou, V.; Malamou-Mitsi, V.; Alamani, M.; Skopa, C.; Kostopoulos, I.; Kastritis, E.; Pectasides, D.; Briasoulis, E.; Kalofonos, H. P.; Aravantinos, G.; Fountzilas, G.; Arapantoni-Dadioti, P.24-Nov-2015-
Expression of organic anion-transporting polypeptides 1B3, 1B1, and 1A2 in human pancreatic cancer reveals a new class of potential therapeutic targetsKounnis, V.; Ioachim, E.; Svoboda, M.; Tzakos, A.; Sainis, I.; Thalhammer, T.; Steiner, G.; Briasoulis, E.24-Nov-2015-
Feasibility study and pharmacokinetics of low-dose paclitaxel in cancer patients with severe hepatic dysfunctionBriasoulis, E.; Karavasilis, V.; Tzamakou, E.; Piperidou, C.; Soulti, K.; Pavlidis, N.24-Nov-2015-
First line combination chemotherapy with docetaxel and vinorelbine in advanced breast cancer. A phase II studyPectasides, D.; Dimopoulos, M. A.; Aravantinos, G.; Kalophonos, H. P.; Papacostas, P.; Briasoulis, E.; Cogas, E.; Papadimitriou, C.; Skarlos, D.; Kosmidis, P.; Fountzilas, G.24-Nov-2015-
G-CSF induces elevation of circulating CA 15-3 in breast carcinoma patients treated in an adjuvant settingBriasoulis, E.; Andreopoulou, E.; Tolis, C. F.; Bairaktari, E.; Katsaraki, A.; Dimopoulos, M. A.; Fountzilas, G.; Seferiadis, C.; Pavlidis, N.24-Nov-2015-
Glufosfamide administered by 1-hour infusion as a second-line treatment for advanced non-small cell lung cancer; a phase II trial of the EORTC-New Drug Development GroupGiaccone, G.; Smit, E. F.; de Jonge, M.; Dansin, E.; Briasoulis, E.; Ardizzoni, A.; Douillard, J. Y.; Spaeth, D.; Lacombe, D.; Baron, B.; Bachmann, P.; Fumoleau, P.24-Nov-2015-
Glufosfamide administered using a 1-hour infusion given as first-line treatment for advanced pancreatic cancer. A phase II trial of the EORTC-new drug development groupBriasoulis, E.; Pavlidis, N.; Terret, C.; Bauer, J.; Fiedler, W.; Schoffski, P.; Raoul, J. L.; Hess, D.; Selvais, R.; Lacombe, D.; Bachmann, P.; Fumoleau, P.24-Nov-2015-
Immunohistochemical expression of extracellular matrix components tenascin, fibronectin, collagen type IV and laminin in breast cancer: their prognostic value and role in tumour invasion and progressionIoachim, E.; Charchanti, A.; Briasoulis, E.; Karavasilis, V.; Tsanou, H.; Arvanitis, D. L.; Agnantis, N. J.; Pavlidis, N.24-Nov-2015-
Immunohistochemical expression of superoxide dismutase (MnSOD) anti-oxidant enzyme in invasive breast carcinomaTsanou, E.; Ioachim, E.; Briasoulis, E.; Damala, K.; Charchanti, A.; Karavasilis, V.; Pavlidis, N.; Agnantis, N. J.24-Nov-2015-
Individualized preventive and therapeutic management of hereditary breast ovarian cancer syndromeRoukos, D. H.; Briasoulis, E.24-Nov-2015-
Showing results 36 to 55 of 126 < previous   next >